CA
DNA icon

Cetera Advisors’s Ginkgo Bioworks DNA Stock Holding History

Cetera Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$404K Buy
8,714
+943
+12% +$48.8K ﹤0.01% 1747
2023
Q4 		$525K Buy
7,771
+675
+10% +$41.3K 0.01% 1097
2023
Q3 		$514K Buy
7,096
+2,567
+57% +$205K 0.01% 1056
2023
Q2 		$337K Buy
4,529
+2,565
+131% +$152K 0.01% 1250
2023
Q1 		$105K Buy
1,964
+929
+90% +$58.9K ﹤0.01% 1561
2022
Q4 		$70K Buy
+1,035
New +$95.2K ﹤0.01% 1532

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Advisors's DNA Position: Q1 2024 in Review

Cetera Advisors increased its Ginkgo Bioworks (DNA) stake by 12% in Q1 2024, buying an estimated $48.8K and bringing the position to 8,714 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Cetera Advisors first reported a position in DNA in Q4 2022 and has held it in 6 quarters since. The position peaked at $525K in Q4 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Cetera Advisors held 8,714 shares of Ginkgo Bioworks worth $404K as of Q1 2024.
  • Cetera Advisors bought 943 Ginkgo Bioworks shares in Q1 2024, an estimated $48.8K.
  • Ginkgo Bioworks made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #1747 holding.
  • Cetera Advisors first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 6 quarters since.
  • Cetera Advisors's Ginkgo Bioworks position peaked at $525K in Q4 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.